Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5177930
Max Phase: Preclinical
Molecular Formula: C58H82N12O12
Molecular Weight: 1139.37
Associated Items:
ID: ALA5177930
Max Phase: Preclinical
Molecular Formula: C58H82N12O12
Molecular Weight: 1139.37
Associated Items:
Canonical SMILES: CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(CC5CCN(C(=O)CCOCCOCCOCCOCCNc6cccc7c6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)CC3)c(OC)c2)nc1NC1CCOCC1
Standard InChI: InChI=1S/C58H82N12O12/c1-3-44-54(61-40-15-27-78-28-16-40)65-55(52(63-44)53(59)73)62-41-7-8-46(48(37-41)77-2)68-21-13-42(14-22-68)67-25-23-66(24-26-67)38-39-11-19-69(20-12-39)50(72)17-29-79-31-33-81-35-36-82-34-32-80-30-18-60-45-6-4-5-43-51(45)58(76)70(57(43)75)47-9-10-49(71)64-56(47)74/h4-8,37,39-40,42,47,60H,3,9-36,38H2,1-2H3,(H2,59,73)(H2,61,62,65)(H,64,71,74)
Standard InChI Key: SCLMTSZFOUQTIR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1139.37 | Molecular Weight (Monoisotopic): 1138.6175 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ohoka N, Suzuki M, Uchida T, Tsuji G, Tsukumo Y, Yoshida M, Inoue T, Demizu Y, Ohki H, Naito M.. (2022) Development of Gilteritinib-Based Chimeric Small Molecules that Potently Induce Degradation of FLT3-ITD Protein., 13 (12.0): [PMID:36518702] [10.1021/acsmedchemlett.2c00402] |
Source(1):